Joel Greenblatt’s Astera Labs ALAB Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$13.8M Buy
28,484
+14,492
+104% +$3.85M 0.03% 715
2026
Q1
$1.53M Buy
13,992
+9,120
+187% +$1.3M ﹤0.01% 1185
2025
Q4
$811K Sell
4,872
-3,792
-44% -$634K ﹤0.01% 1326
2025
Q3
$1.7M Buy
+8,664
New +$1.42M 0.01% 1045
2025
Q1
Sell
-2,398
Closed -$318K 1677
2024
Q4
$318K Sell
2,398
-2,128
-47% -$200K ﹤0.01% 1244
2024
Q3
$237K Buy
+4,526
New +$212K ﹤0.01% 1301

Other funds holding ALAB

Joel Greenblatt's ALAB Position: Q2 2026 in Review

Joel Greenblatt increased its Astera Labs (ALAB) stake by 104% in Q2 2026, buying an estimated $3.85M and bringing the position to 28,484 shares worth $13.8M. The position accounts for 0.03% of the portfolio, ranked #715.

Joel Greenblatt first reported a position in ALAB in Q3 2024 and has held it in 6 quarters since. 984 funds tracked by Wall St. Rank hold ALAB as of Q2 2026.

  • Joel Greenblatt held 28,484 shares of Astera Labs worth $13.8M as of Q2 2026.
  • Joel Greenblatt bought 14,492 Astera Labs shares in Q2 2026, an estimated $3.85M.
  • Astera Labs made up 0.03% of Joel Greenblatt's portfolio in Q2 2026, its #715 holding.
  • Joel Greenblatt first reported a position in Astera Labs in Q3 2024 and has held it in 6 quarters since.
  • 984 funds tracked by Wall St. Rank held Astera Labs as of Q2 2026.

Based on Gotham Asset Management's 13F filing for Q2 2026, filed 14 Aug 2026.